Dr. Mitchell on Clinical Trials Exploring Medical Marijuana for Patients With Cancer

Jerry W. Mitchell, MD
Published: Wednesday, Oct 25, 2017



Jerry W. Mitchell, MD, oncologist, Zangmeister Cancer Center, discusses clinical trials exploring medical marijuana for patients with cancer.

A recent small-scale trial published in the New England Journal of Medicine looked at seizures in patients with Dravet syndrome, or severe myoclonic epilepsy of infancy, which demonstrated a reduction in the seizure rate with the use of medical marijuana.

Both the Dravet syndrome and chronic pain trials have had some problems, Mitchell explains. However, medical marijuana seems to have a generally positive effect on chronic pain, says Mitchell.

There were approximately 62,000 opioid-related deaths in the United States in 2016, so Mitchell believes it is important to have this tool that has reportedly never resulted in an overdose death to help ease pain for patients with cancer.
SELECTED
LANGUAGE


Jerry W. Mitchell, MD, oncologist, Zangmeister Cancer Center, discusses clinical trials exploring medical marijuana for patients with cancer.

A recent small-scale trial published in the New England Journal of Medicine looked at seizures in patients with Dravet syndrome, or severe myoclonic epilepsy of infancy, which demonstrated a reduction in the seizure rate with the use of medical marijuana.

Both the Dravet syndrome and chronic pain trials have had some problems, Mitchell explains. However, medical marijuana seems to have a generally positive effect on chronic pain, says Mitchell.

There were approximately 62,000 opioid-related deaths in the United States in 2016, so Mitchell believes it is important to have this tool that has reportedly never resulted in an overdose death to help ease pain for patients with cancer.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Year in Review™: Reflecting on Recent Evidence for the Treatment of Hematologic MalignanciesFeb 28, 20192.0
Publication Bottom Border
Border Publication
x